Results 271 to 280 of about 2,003,708 (339)
Some of the next articles are maybe not open access.

Endometrial carcinoma of prostate

Urology, 1986
In the rare group of atypical adenocarcinomas of the prostate gland, endometrial carcinoma arising from the prostatic utricle can be perplexing to diagnose because of its histologic similarity with other ductal carcinomas and frequent simultaneous admixture of microacinar adenocarcinomas. Two cases of endometrial carcinoma of the prostate are detailed,
openaire   +2 more sources

Chemotherapy of Prostatic Carcinoma

1993
In 1941 Huggins and Hodges [22] demonstrated the effect of androgen deprivation on prostatic carcinoma in experimental studies and by clinical observation. Since then, androgen deprivation has become the standard treatment of metastatic prostate cancer.
H, RĂ¼bben, K, Rembrink, T, Johnston
openaire   +2 more sources

CARCINOMA OF THE PROSTATE

Journal of the American Geriatrics Society, 1953
V F, MARSHALL, W F, WHITMORE
openaire   +4 more sources

Carcinoma of the Prostate

The American Journal of Nursing, 1948
M R, VAN SCHOICK, C, HUGGINS
openaire   +2 more sources

Epidemiology of Prostate Carcinoma

1977
Thorough and comprehensive reviews exist on the epidemiology of carcinoma of the prostate (7, 16, 19, 31). In reviewing descriptive epidemiology of the disease, this chapter will give mortality and incidence rates for carcinoma of the prostate in Iceland. It will also mention some suggestions as to etiology.
openaire   +2 more sources

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

American Journal of Surgical Pathology, 2005
J. Epstein   +3 more
semanticscholar   +1 more source

Management of carcinoma of the prostate

Hospital Medicine, 1999
Every year in the UK nearly 10 000 men die from advanced prostate cancer. On average these individuals lose 9 years of their anticipated lifespan. The cumulative loss of expected life years therefore amounts to around 90 000 per annum, and many hundreds of thousands more retirement years are blighted or lost worldwide as a consequence of this very ...
openaire   +2 more sources

Metastatic poorly differentiated prostatic carcinoma with neuroendocrine differentiation: negative on 68Ga-PSMA PET/CT.

Clinical Nuclear Medicine, 2015
P. Chakraborty   +5 more
semanticscholar   +1 more source

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.

New England Journal of Medicine, 1989
E. Crawford   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy